Ticker Scorecard - BLUE Basics Company: bluebird bio, Inc. Common Stock IPO Date: June 19, 2013 Sector: Healthcare Industry: Biotech Market Cap: $39.67M Activated in VL: True Average Daily Range Avg Daily Range: $1.49 | 3.16% Avg Daily Range (30 D): $0.28 | 3.90% Avg Daily Range (90 D): $0.24 | 6.34% Institutional Daily Volume Avg Daily Volume: 1.47M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 127 Avg Trade Size (Sh.) (30 D): 123 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 5,472 Avg Inst. Trade: $3.12M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.75M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.07M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $.73M Avg Closing Volume: 9.19K     News Feb 21, 2025 @ 1:53 PM What's Going On With Gene Therapy Company Bluebird... Source: Nabaparna Bhattacharya Feb 11, 2025 @ 11:48 AM EMV POS Terminal Global Strategic Business Report ... Source: Researchandmarkets.Com Dec 26, 2024 @ 12:18 PM Gene Therapy Market Analysis,Growth, Insights and ... Source: Exactitude Consultancy Dec 22, 2024 @ 5:25 PM This Beaten-Down Biotech Stock Just Got Some Good ... Source: Prosper Junior Bakiny Oct 26, 2024 @ 10:32 AM The Ultimate Biotech Stock to Buy With $50 Right N... Source: Prosper Junior Bakiny Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.8 $-.31 $-.42 Diluted EPS $-1.8 $-.31 $-.42 Revenue $ 53.12M $ 10.61M $ 16.1M Gross Profit $ -25.66M $ -1.17M $ -12.85M Net Income / Loss $ -292.83M $ -60.81M $ -81.39M Operating Income / Loss $ -321.29M $ -66.92M $ -88.39M Cost of Revenue $ 78.78M $ 11.78M $ 28.95M Net Cash Flow $ -99.72M $ -74.57M $ -70.69M PE Ratio     Splits Dec 13, 2024:   20:1